Whitepaper: Characterising insulin as a biopharmaceutical using Analytical Ultracentrifugation
AUC was used to probe the effect of insulin concentration and the zinc chelating agent EDTA on monomer, dimer, and hexamer formation of USP Human Insulin Standard.
Today, large efforts are currently being undertaken by biopharmaceutical companies to create insulin derivatives and novel formulation to improve efficacy, administration methods, and time action profiles. In future development of insulin analogs, the effect of excipients such as zinc will need to be considered on the assembly state of the drug.
AUC as demonstrated in this application note, is shown to be useful in assessing the level of non-covalent aggregates such as the insulin hexamer.
Related content from this organisation
- Whitepaper: Characterising insulin as a biopharmaceutical using Analytical Ultracentrifugation
- Product hub: New MET ONE 3400+ air particle counter
- Data sheet: Viral RNA extraction from saliva and swab samples
- Application note: Streamlined synthetic biology with acoustic liquid handling
- Application note: Automated ELISA solutions – workflow intelligence guide
Analytical techniques, Artificial Intelligence, Biologics, Biopharmaceuticals, Bioprocessing, Biosimilars, Chromatography, Formulation, Good Manufacturing Practice (GMP), Manufacturing, Proteomics, QA/QC, Research & Development (R&D), Vaccines